Loading...
XJPX7707
Market cap39mUSD
Dec 25, Last price  
225.00JPY
1D
-2.17%
1Q
-20.49%
Jan 2017
-44.72%
Name

Precision System Science Co Ltd

Chart & Performance

D1W1MN
XJPX:7707 chart
P/E
—
P/S
1.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.42%
Rev. gr., 5y
-1.90%
Revenues
3.98b
-24.60%
3,397,932,0003,802,466,0005,637,771,0003,142,760,0003,520,274,0004,029,396,0003,921,722,0005,143,465,0004,458,411,0003,847,021,0003,641,164,0004,381,442,0005,067,231,0009,298,741,0007,434,287,0005,278,321,0003,979,954,000
Net income
-1.12b
L-15.31%
-400,557,00073,599,000549,992,000-366,678,000-189,057,0001,014,386,000611,958,000-215,220,000-1,582,050,000-555,218,000-457,616,000130,318,000-114,275,000795,985,00045,337,000-1,324,290,000-1,121,480,000
CFO
-107m
L+1,483.18%
199,351,000339,751,000407,281,000-403,391,000-396,598,000-35,239,000-822,599,000-1,362,603,00072,149,000-802,766,000-32,812,000-403,711,000-21,452,000-280,966,000869,161,000-6,746,000-106,801,000
Dividend
Jun 29, 20215 JPY/sh

Profile

Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally. The company manufactures and sells plastic consumables, which are used in automated systems/instruments, as well as reagents; and automated nucleic acid extraction and veterinary biochemical analysis systems. It also offers geneLEAD, an instrument for molecular testing; and engages in the research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was founded in 1985 and is headquartered in Matsudo, Japan.
URL
https://www.pss.co.jp/
IPO date
Feb 01, 2001
Employees
196
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
3,979,954
-24.60%
5,278,321
-29.00%
7,434,287
-20.05%
Cost of revenue
3,245,577
4,303,541
5,332,194
Unusual Expense (Income)
NOPBT
734,377
974,780
2,102,093
NOPBT Margin
18.45%
18.47%
28.28%
Operating Taxes
19,077
48,389
122,092
Tax Rate
2.60%
4.96%
5.81%
NOPAT
715,300
926,391
1,980,001
Net income
(1,121,480)
-15.31%
(1,324,290)
-3,020.99%
45,337
-94.30%
Dividends
(138,334)
Dividend yield
0.96%
Proceeds from repurchase of equity
(2)
(16)
538,401
BB yield
0.00%
0.00%
-3.75%
Debt
Debt current
1,076,960
1,344,143
1,347,398
Long-term debt
289,673
2,527,394
2,676,510
Deferred revenue
2,496
Other long-term liabilities
3,154
5,051
8,296
Net debt
(603,759)
1,266,180
1,132,408
Cash flow
Cash from operating activities
(106,801)
(6,746)
869,161
CAPEX
(12,000)
(155,285)
(2,249,171)
Cash from investing activities
2,056,789
(213,704)
(2,285,133)
Cash from financing activities
(2,508,350)
(154,054)
93,735
FCF
3,446,467
1,976,198
676,516
Balance
Cash
1,915,220
2,446,357
2,763,500
Long term investments
55,172
159,000
128,000
Excess cash
1,771,394
2,341,441
2,519,786
Stockholders' equity
(1,531,719)
4,091,196
5,381,317
Invested Capital
7,044,356
6,728,812
7,994,398
ROIC
10.39%
12.58%
27.27%
ROCE
13.32%
10.74%
19.99%
EV
Common stock shares outstanding
27,631
27,631
27,634
Price
190.00
-44.61%
343.00
-34.04%
520.00
-37.50%
Market cap
5,249,962
-44.61%
9,477,570
-34.04%
14,369,548
-36.85%
EV
4,646,203
10,743,750
15,501,956
EBITDA
1,143,458
1,616,007
2,636,867
EV/EBITDA
4.06
6.65
5.88
Interest
31,570
40,620
38,128
Interest/NOPBT
4.30%
4.17%
1.81%